Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir

Seung Bum Lee, Joonho Jeong, Jae Ho Park, Seok Won Jung, In Du Jeong, Sung-Jo Bang, Jung Woo Shin, Bo Ryung Park, Eun Ji Park, Neung Hwa Park

Clin Mol Hepatol. 2020;26(3):364-375. Published online May 29, 2020

DOI: https://doi.org/10.3350/cmh.2020.0012

View: 5788 Download: 266 Web of Science: 24 Crossref: 21

High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice

Nae-Yun Heo, Young-Suk Lim, Han Chu Lee, Yung Sang Lee, Kang Mo Kim, Kwan Soo Byun, Kwang-Hyub Han, Kwan Sik Lee, Seung Woon Paik, Seung Kew Yoon, Dong Jin Suh

Clin Mol Hepatol. 2013;19(1):60-69. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.60

View: 8438 Download: 61 Web of Science: 6 Crossref: 7

3

Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response

Soung Won Jeong, M.D., Jin Dong Kim, M.D. Hyun Young Woo, M.D. Chan Ran You, M.D. Sung Won Lee, M.D. Myeong Jun Song, M.D. Jung Won Jang, M.D. Si Hyun Bae, M.D. Jong Young Choi, M.D. Seung Kew Yoon, M.D.

Clin Mol Hepatol. 2009;15(3):338-349. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.338

View: 4620 Download: 24 Crossref: 11

1 |

Viewed By 5414	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5378	MAFLD: How is it different from NAFLD?
Viewed By 5268	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3935	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3924	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search